Literature DB >> 22633655

Aggressive cardiovascular phenotype of aneurysms-osteoarthritis syndrome caused by pathogenic SMAD3 variants.

Denise van der Linde1, Ingrid M B H van de Laar, Aida M Bertoli-Avella, Rogier A Oldenburg, Jos A Bekkers, Francesco U S Mattace-Raso, Anton H van den Meiracker, Adriaan Moelker, Fop van Kooten, Ingrid M E Frohn-Mulder, Janneke Timmermans, Els Moltzer, Jan M Cobben, Lut van Laer, Bart Loeys, Julie De Backer, Paul J Coucke, Anne De Paepe, Yvonne Hilhorst-Hofstee, Marja W Wessels, Jolien W Roos-Hesselink.   

Abstract

OBJECTIVES: The purpose of this study was describe the cardiovascular phenotype of the aneurysms-osteoarthritis syndrome (AOS) and to provide clinical recommendations.
BACKGROUND: AOS, caused by pathogenic SMAD3 variants, is a recently described autosomal dominant syndrome characterized by aneurysms and arterial tortuosity in combination with osteoarthritis.
METHODS: AOS patients in participating centers underwent extensive cardiovascular evaluation, including imaging, arterial stiffness measurements, and biochemical studies.
RESULTS: We included 44 AOS patients from 7 families with pathogenic SMAD3 variants (mean age: 42 ± 17 years). In 71%, an aortic root aneurysm was found. In 33%, aneurysms in other arteries in the thorax and abdomen were diagnosed, and in 48%, arterial tortuosity was diagnosed. In 16 patients, cerebrovascular imaging was performed, and cerebrovascular abnormalities were detected in 56% of them. Fifteen deaths occurred at a mean age of 54 ± 15 years. The main cause of death was aortic dissection (9 of 15; 60%), which occurred at mildly increased aortic diameters (range: 40 to 63 mm). Furthermore, cardiac abnormalities were diagnosed, such as congenital heart defects (6%), mitral valve abnormalities (51%), left ventricular hypertrophy (19%), and atrial fibrillation (22%). N-terminal brain natriuretic peptide (NT-proBNP) was significantly higher in AOS patients compared with matched controls (p < 0.001). Aortic pulse wave velocity was high-normal (9.2 ± 2.2 m/s), indicating increased aortic stiffness, which strongly correlated with NT-proBNP (r = 0.731, p = 0.005).
CONCLUSIONS: AOS predisposes patients to aggressive and widespread cardiovascular disease and is associated with high mortality. Dissections can occur at relatively mildly increased aortic diameters; therefore, early elective repair of the ascending aorta should be considered. Moreover, cerebrovascular abnormalities were encountered in most patients.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22633655     DOI: 10.1016/j.jacc.2011.12.052

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  46 in total

1.  New Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3).

Authors:  Helena Kuivaniemi; Natzi Sakalihasan; Frank A Lederle; Gregory T Jones; Jean-Olivier Defraigne; Nicos Labropoulos; Victor Legrand; Jean-Baptiste Michel; Christoph Nienaber; Marc A Radermecker; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2013-06-01

2.  Genes in thoracic aortic aneurysms/dissections - do they matter?

Authors:  Julie De Backer; Laurence Campens; Anne De Paepe
Journal:  Ann Cardiothorac Surg       Date:  2013-01

Review 3.  Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome.

Authors:  Josephina A N Meester; Aline Verstraeten; Dorien Schepers; Maaike Alaerts; Lut Van Laer; Bart L Loeys
Journal:  Ann Cardiothorac Surg       Date:  2017-11

4.  Thoracic aortic dissection and heritability: forensic implications.

Authors:  Elizabeth N Robertson; Brett D Hambly; Richmond W Jeremy
Journal:  Forensic Sci Med Pathol       Date:  2016-07-08       Impact factor: 2.007

Review 5.  Arterial tortuosity in genetic arteriopathies.

Authors:  Shaine A Morris
Journal:  Curr Opin Cardiol       Date:  2015-11       Impact factor: 2.161

Review 6.  Genetic testing in cardiovascular diseases.

Authors:  Anne-Karin Arndt; Calum A MacRae
Journal:  Curr Opin Cardiol       Date:  2014-05       Impact factor: 2.161

Review 7.  Genes Associated with Thoracic Aortic Aneurysm and Dissection: An Update and Clinical Implications.

Authors:  Adam J Brownstein; Bulat A Ziganshin; Helena Kuivaniemi; Simon C Body; Allen E Bale; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2017-02-01

Review 8.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

9.  GM-CSF contributes to aortic aneurysms resulting from SMAD3 deficiency.

Authors:  Ping Ye; Wenhao Chen; Jie Wu; Xiaofan Huang; Jun Li; Sihua Wang; Zheng Liu; Guohua Wang; Xiao Yang; Peng Zhang; Qiulun Lv; Jiahong Xia
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

10.  Genes in Thoracic Aortic Aneurysms and Dissections - Do they Matter?: Translation and Integration of Research and Modern Genetic Techniques into Daily Clinical Practice.

Authors:  Julie De Backer; Marjolijn Renard; Laurence Campens; Katrien François; Bert Callewaert; Paul Coucke; Anne De Paepe
Journal:  Aorta (Stamford)       Date:  2013-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.